- Home
- BHVN vs CLOV Comparison
BHVN vs CLOV Comparison
Compare BHVN & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHVN
- CLOV
- Stock Information
- Founded
- BHVN 2013
- CLOV 2014
- Country
- BHVN United States
- CLOV United States
- Employees
- BHVN N/A
- CLOV N/A
- Industry
- BHVN Biotechnology: Pharmaceutical Preparations
- CLOV Medical Specialities
- Sector
- BHVN Health Care
- CLOV Health Care
- Exchange
- BHVN Nasdaq
- CLOV Nasdaq
- Market Cap
- BHVN 1.5B
- CLOV 1.5B
- IPO Year
- BHVN 2017
- CLOV N/A
- Fundamental
- Price
- BHVN $15.66
- CLOV $2.73
- Analyst Decision
- BHVN Strong Buy
- CLOV Strong Buy
- Analyst Count
- BHVN 14
- CLOV 3
- Target Price
- BHVN $54.62
- CLOV $4.37
- AVG Volume (30 Days)
- BHVN 2.3M
- CLOV 8.6M
- Earning Date
- BHVN 08-11-2025
- CLOV 08-05-2025
- Dividend Yield
- BHVN N/A
- CLOV N/A
- EPS Growth
- BHVN N/A
- CLOV N/A
- EPS
- BHVN N/A
- CLOV N/A
- Revenue
- BHVN N/A
- CLOV $1,607,900,000.00
- Revenue This Year
- BHVN N/A
- CLOV $38.62
- Revenue Next Year
- BHVN $1,007.82
- CLOV $22.21
- P/E Ratio
- BHVN N/A
- CLOV N/A
- Revenue Growth
- BHVN N/A
- CLOV 22.12
- 52 Week Low
- BHVN $12.79
- CLOV $2.12
- 52 Week High
- BHVN $55.70
- CLOV $4.87
- Technical
- Relative Strength Index (RSI)
- BHVN 56.24
- CLOV 51.21
- Support Level
- BHVN $14.23
- CLOV $2.12
- Resistance Level
- BHVN $16.14
- CLOV $2.73
- Average True Range (ATR)
- BHVN 0.86
- CLOV 0.14
- MACD
- BHVN 0.10
- CLOV 0.02
- Stochastic Oscillator
- BHVN 85.48
- CLOV 71.76
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
About CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.